Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL517250 | 0.89 | ALDH1A1 (0.45) | ALDH1A1DGAT1KCNN4CTRB1MEN1 | |
| SCHEMBL10053403 | 0.80 | LMNA (0.39) | — | |
| SCHEMBL10763959 | 0.79 | ALDH1A1 (0.39) | ALDH1A1DGAT1KCNN4MEN1KMT2A | |
| SCHEMBL22767945 | 0.79 | ALDH1A1 (0.39) | ALDH1A1DGAT1KCNN4CTRB1MEN1 | |
| SCHEMBL517272 | 0.78 | DGAT1 (0.39) | ALDH1A1DGAT1KCNN4CTRB1MEN1 | |
| SCHEMBL1129794 | 0.78 | ALDH1A1 (0.42) | ALDH1A1DGAT1KCNN4MEN1KMT2A | |
| SCHEMBL497763 | 0.78 | DGAT1 (0.39) | ALDH1A1DGAT1KCNN4CTRB1MEN1 | |
| SCHEMBL10485166 | 0.77 | ALDH1A1 (0.38) | ALDH1A1DGAT1KCNN4MEN1KMT2A | |
| SCHEMBL3082673 | 0.76 | THRB (0.40) | ALDH1A1DGAT1KCNN4GAA | |
| SCHEMBL14569119 | 0.76 | ALDH1A1 (0.41) | ALDH1A1DGAT1KCNN4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481774-B2 | Method for producing tetrafluoro compound | NIPPON SODA CO., LTD. (JP) | 2013-07-09 | — | — | US | disclosed |
| US-20110178323-A1 | METHOD FOR PRODUCING TETRAFLUORO COMPOUND | NIPPON SODA CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178323-A1 | METHOD FOR PRODUCING TETRAFLUORO COMPOUND | F9, CA9, TAF9 | ALDH1A1 3848/4885DGAT1 2042/4885KCNN4 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.